Health authorities in the United Kingdom have expanded eligibility for the meningitis B (MenB) vaccine after the number of cases linked to an outbreak in Kent rose to 27, sparking urgent public health action.
The outbreak, centred in Canterbury and linked to a nightclub cluster, has primarily affected students and young people. Officials confirmed that those who visited the venue between March 5 and 15, as well as students from nearby universities and schools, are now eligible for both preventive antibiotics and vaccination.
Initially, vaccination efforts targeted a smaller group, including students living in university accommodation. However, as infections increased and concerns grew about wider transmission, the programme was rapidly broadened. Health Secretary Wes Streeting said the expansion aims to “contain the outbreak” and protect those at highest risk.
Also Read: Top 10 Immunity Booster Drinks to Stay Healthy and Strong
Two deaths—a university student and a school pupil—have been reported, underscoring the seriousness of the situation. Thousands of antibiotic doses have already been distributed, and vaccination clinics have been scaled up across Kent.
Experts from the UK Health Security Agency (UKHSA) have reassured the public that the available MenB vaccine is effective against the strain involved, while emphasizing the importance of early symptom recognition.
Although officials say the outbreak is not yet a national emergency, they warn that additional cases may emerge due to the disease’s incubation period. Expanded vaccine access and rapid response measures are expected to play a key role in limiting further spread.
Also Read: Meningitis
